Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 2/2021

01-04-2021 | Correction

Correction to: Letter to the Editor—Recent advances in Lynch syndrome: response to Møller et al.

Authors: Leah H. Biller, Sapna Syngal, Matthew B. Yurgelun

Published in: Familial Cancer | Issue 2/2021

Login to get access

Excerpt

Unfortunately, the original article title had been published as "Recent advances in Lynch syndrome: response to Møller et al." The correct title is "Letter to the Editor - Recent advances in Lynch syndrome: response to Møller et al." …
Metadata
Title
Correction to: Letter to the Editor—Recent advances in Lynch syndrome: response to Møller et al.
Authors
Leah H. Biller
Sapna Syngal
Matthew B. Yurgelun
Publication date
01-04-2021
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 2/2021
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-021-00245-1

Other articles of this Issue 2/2021

Familial Cancer 2/2021 Go to the issue

Correction

Correction to: Letter to the Editor—Recent advances in Lynch syndrome

Original Article

Is a colorectal neoplasm diagnosis a trigger to change dietary and other lifestyle habits for persons with Lynch syndrome? A prospective cohort study

Letter to the Editor

Letter to the Editor-Recent advances in Lynch syndrome

Original Article

Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy

Original Article

Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas

Original Article

Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits